Richter Takes Control Of German JVs To Wrap Up Teriparatide Biosimilar

Majority Owned CDMO With Three Sites Also Set To Move Into Richter’s Hands

Gedeon Richter is putting its hand back in its wallet following its recent investment in Formycon, opting to take control of a pair of joint ventures established with German firm Helm.

old abacus with bills of 500 euros close up

Hungarian player Gedeon Richter has struck agreements worth more than €100m ($109m) to buy out a couple of joint ventures from its long-term German partner Helm, including a JV (Richter-Helm BioLogics) that owns the Terrosa (teriparatide) biosimilar to Forteo/Forsteo, in a move it believes will “create a very strong biotechnology platform allowing even better service offerings in a cost-efficient way.”

Through a €71.8m purchase agreement, Richter is seeking to buy out Helm’s 50% stake in Richter-Helm BioTec GmbH & Co....

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business